Prognostic value of interim [18F]FDG PET/CT after immunotherapy-based combinations in extranodal NK/T-cell lymphoma, nasal type

被引:0
作者
Liu, Lei [1 ]
Hao, Shihui [1 ]
Chen, Wanqi [1 ]
Jing, Ming [2 ]
Li, Shatong [1 ]
Zhang, Weiguang [1 ]
Liang, Liping [1 ]
Wei, Fan [1 ]
Zhang, Yujing [2 ]
机构
[1] Sun Yat Sen Univ, Guangdong Prov Clin Res Ctr Canc, Dept Nucl Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
[2] Sun Yat sen Univ, Guangdong Prov Clin Res Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
关键词
Extranodal NK-T-cell lymphomas; Immunotherapy; PET/CT; Prognosis; FDG-PET; RESPONSE ASSESSMENT; F-18-FDG PET/CT; MULTICENTER; SCAN; CRITERIA; THERAPY; HODGKIN; CT;
D O I
10.1007/s00330-024-11276-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To evaluate the prognostic value of interim [F-18]Fluorodeoxyglucose positron emission tomography/computed tomography ([F-18]FDG PET/CT) after immunotherapy-based systemic therapies in extranodal natural killer/T-cell lymphoma (ENKTL). Patients and methods We retrospectively recruited 133 newly diagnosed nasal-type ENKTL patients who underwent interim [F-18]FDG PET/CT scans after 2-4 cycles of immunotherapy-based treatments. Interim PET/CT was interpreted by maximum standardized uptake value (SUVmax), Deauville 5-point scale (DS), and early treatment response. The prognostic value of overall survival (OS) and progression-free survival (PFS) was assessed with survival curves generated using Kaplan-Meier analysis and compared using the log-rank test. Univariate and multivariate Cox proportional hazards analyses were performed to evaluate the independent effects for survival. Model performance was assessed with a time-dependent area under the curve (time-AUC), concordance index (C-index), and the Akaike information criterion (AIC). Results Patients with high SUVmax (> 9.2), DS 5, or with stable disease (SD) or relapsed/progressive disease (PD) on interim PET/CT showed significantly unfavorable OS and PFS with the Kaplan-Meier estimate, respectively. The interim PET/CT parameters remained independent predictors for both OS and PFS after univariate and multivariate analysis. We combined interim DS with the prognostic index for natural killer cell lymphoma-Epstein-Barr virus (PINK-E) model to stratify our cohort into 3 risk categories: low-risk (0-2 risk factors), intermediate-risk (3 risk factors), and high-risk (>= 4 risk factors), which showed significant and superior stratifications of OS and PFS than PINK-E. Conclusion Interim PET/CT after immunotherapy-based systemic treatments showed independent prognostic value for ENKTL. The model combining interim PET/CT with PINK-E might be an effective prognostic tool.
引用
收藏
页码:4213 / 4222
页数:10
相关论文
共 40 条
[1]   Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (11) :1963-1970
[2]   Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 :55-63
[3]   Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study [J].
Ai, Weiyun Z. ;
Chang, Ellen T. ;
Fish, Kari ;
Fu, Kai ;
Weisenburger, Dennis D. ;
Keegan, Theresa H. M. .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) :626-632
[4]   Quantitative PET-based biomarkers in lymphoma: getting ready for primetime [J].
Alderuccio, Juan Pablo ;
Kuker, Russ A. ;
Yang, Fei ;
Moskowitz, Craig H. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (09) :640-657
[5]  
Andre MPE, 2024, EARLY POSITRON EMISS
[6]   Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project [J].
Au, Wing-yan ;
Weisenburger, Dennis D. ;
Intragumtornchai, Tanin ;
Nakamura, Shigeo ;
Kim, Won-Seog ;
Sng, Ivy ;
Vose, Julie ;
Armitage, James O. ;
Liang, Raymond .
BLOOD, 2009, 113 (17) :3931-3937
[7]   FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas [J].
Barrington, Sally F. ;
Kluge, Regine .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S97-S110
[8]   Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[9]  
Biggi A, 2024, INT VALIDATION STUDY
[10]   FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 [J].
Boellaard, Ronald ;
Delgado-Bolton, Roberto ;
Oyen, Wim J. G. ;
Giammarile, Francesco ;
Tatsch, Klaus ;
Eschner, Wolfgang ;
Verzijlbergen, Fred J. ;
Barrington, Sally F. ;
Pike, Lucy C. ;
Weber, Wolfgang A. ;
Stroobants, Sigrid ;
Delbeke, Dominique ;
Donohoe, Kevin J. ;
Holbrook, Scott ;
Graham, Michael M. ;
Testanera, Giorgio ;
Hoekstra, Otto S. ;
Zijlstra, Josee ;
Visser, Eric ;
Hoekstra, Corneline J. ;
Pruim, Jan ;
Willemsen, Antoon ;
Arends, Bertjan ;
Kotzerke, Joerg ;
Bockisch, Andreas ;
Beyer, Thomas ;
Chiti, Arturo ;
Krause, Bernd J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :328-354